Bioanalytical and Theoretical Studies of the Spectrophotometrically Investigated Iridium (III)-3-Hydroxy-2-(4-Methoxyphenyl)-4H-Chromen-4-one Complex

Document Type : Research Article


1 Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala-13320, INDIA

2 Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala-133207, INDIA

3 Department of Human Genetics and Molecular Medicine, School of Health sciences, central University of Punjab, Bathinda-151401, INDIA

4 Department of Chemistry, Kurukshetra University, Kurukshetra

5 Department of Chemistry, Kurukshetra University, Kurukshetra-136119, INDIA

6 Department of Chemistry, Institute of H. Science, Dr. Bhimrao Ambedkar University, Agra-282002, UP, INDIA

7 Department of Physics, Aringnar Anna Govt. Arts College, Cheyyar-604407, INDIA


A pioneering approach for the spectrophotometric inquisition of microscale amounts of iridium (III) under aqueous conditions has been explored using a novel benzopyran derivative, 3-hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one (HMPC) as a ligand, hence, employing complexation as a basis of reaction between the two. The spontaneous complexation between iridium (III) and HMPC is manifested by the expeditious formation of a pale yellow complex at pH 4.87 in which the metal-to-ligand ratio [M:L] is estimated as 1:2. The complex absorbs paramountly at 423-430 nm and is markedly stable. For ensuring the formation of a stable complex, optimal conditions have been fixed concerning the parameters regulating its formation. Accordingly, the system shows coherence to linearity between 0.0-1.7 µg/mL of iridium (III). The molar attenuation coefficient and Sandell’s sensitivity are 6.824×104 L/mol cm and 0.00281µg Ir (III) cm-2, respectively at 425 nm. Statistical parameters including RSD, correlation coefficient (r), and detection limit are respectively, 0.2169%, 0.9999, and 0.0123 µg/mL. As a check for flexibility and usability of the method, intervention concerning complexing agents and cations of prime analytical importance has been carried out indicating the majority of these do not induce any interference during determination. The accomplished studies serve as proof of the versatility, flexibility, and sensitivity of the method. Keeping in view the aforesaid characteristics of the complex, it was subjected to numerous biological investigations and has been satisfyingly found to possess anti-cancerous, bactericidal, and antioxidant properties thus expanding its novel utility domain in the therapeutic world. Quantum chemical parameters (DFT and MEP), based on analysis of electronic properties of the complex in its most stable least energy conformation, are used to better understand the chemistry of the produced complex.


Main Subjects

[1] ElGuindy M., Platinum Group Metals: Alloying, Properties, and Applications, Encycl. Mater. Sci. Tech., Oxford, 7117-21 (2001).
[3] Livingstone S.E., “The Chemistry of Ruthenium, Rhodium, Palladium , Osmium , Iridium and Platinum in Comprehensive Inorganic Chemistry”, Pergamon Press Ltd., Headington Hill Hall, Oxford, OX3 OBW, England (1975).
[4] Wang G., Zhou M., Goettel J. T., Schrobilgen G. J., Su J., Li J., Schloder T., Riedel S., Identification of an Iridium-Containing Compound with a Formal Oxidation State of IX, Nature, 514: 475-477 (2014).
[5] Singh S.B., Iridium Chemistry and its Catalytic Applications: A Brief Review, Green Chem. Tech Let., 2: 206-210 (2016).
[6] Liu Z., Sadler P.J., Organoiridium Complexes: Anticancer Agents and Catalysts, Acc. Chem. Res. 47:1174-1185 (2014).
[7] Lu L., Liu L., Chao W., Zhong H., Wang M., Chen X., Lu J., Li R., Dik-Lun M.A., Chung-Hang L., identification of an Iridium (III) Complex with Anti-Bacterial and Anti-Cancer Activity, Sci. Rep., 5: 14544 (2015).
[8] Konkankit C., Marker S., Knopf K., Wilson J.,  Anticancer Activity of the Third Row Transition Metals, Rhenium, Osmium and Iridium, Dalton Trans 47: 9934-9974 (2018).
[11] Tsutomu M., Yuto L., Shun S., Precise Determination of Iridium by Neutron Activation Analysis coupled with Internal Standard Method, J. Radioanal. Nucl. Chem., 324: 1007-1012 (2020).
[12]  Druskovic V., V. Vojkovic, Miko S., Spectrofluorimetric Determination of Iridium (IV) Traces Using 4-Pyridone Derivatives, Talanta, 62:489-495 (2004).
[13] Ingo O., Michael S., Heike S., William S.S., Gust R., Atomic Absorption Spectrometric Determination of Iridium Content in Tumor Cells Exposed to an Iridium Metallodrug, J. Pharm. Biomed. Anal. 47: 938-942 (2008).
[17] Mohmad M., Agnihotri N., Kumar V., Kumar R., Kaviani S., Iridium (III)-3-Hydroxy-2-(3’-Methyl-2’-Thienyl)-4-oxo-4H-1-Benzopyran Complex: The Analytical, In-vitro Antibacterial and DFT Studies, Inorg.  Chem. Commun., 139: 109333  (2022).
[23] Lapasam A., Shadap L., Tripathi D.K., Poluri K.M., Kaminsky W., Kollipara M.R., Arene Ruthenium, Rhodium and Iridium Complexes Containing Benzamide Derivative Ligands; Study of Interesting Bonding Modes, Antibacterial, Antioxidant and DNA Binding Studies, J. Organomet. Chem., 937: 121731 (2021).
[24] Lapasam A., Mawnai I.L., Banothu B., Kaminsky W.,  Kollipara M.R., Ruthenium, Rhodium and Iridium Complexes Containing Pyrimidine Based Thienyl Pyrazoles: Synthesis and Antibacterial Studies, J. Organomet. Chem., 911: 121155 (2020).
[25] Quan H.A.N., Yan-yan H. U. O., Hong C., Anticancer and Antibacterial Activity in-Vitro Evaluation of Iridium (III) Polypyridyl Complexes, J. Bio. Inorg. Chem., 24: 151-169 (2019).
[26] Kollipara M.R ,.Shadap L., Banothu V., Agarwal N., Fluorenone Schiff Base Derivative Complexes of Ruthenium, Rhodium and Iridium Exhibiting Efficient Antibacterial Activity and DNA-Binding Affinity, J. Organomet. Chem., 915: 121246 (2020).
[27] Dhonchak C., Agnihotri N., Kumar A., Zirconium (IV)-3-Hydroxy-2-Tolyl-4H-Chromen-4-One Complex- The Analytical and DFT Studies, J. Mol. Model., 27: 336 (2021).
[29] Algar J., Flynn J. P., A New Method for the Synthesis of Flavones, Proc. R. Ir. Acad., 42B: 1-8 (1934);
     Oyamada T., A New General Method for the Synthesis of the Derivatives of Flavonol, Bull. Chem. Soc. Jpn., 10: 182- 186 (1935);
     Wera, M., Serdiuk, I., Roshal, A., Jerzy, B., 3-Hydroxy-2-(4-Methoxyphenyl)-4H-Chromen-4-One, Acta Cryst., E67: 0440 (2011).
[30] Kumar A., Trivedi M., Bhaskaran S.R.K., Singh G., Synthetic, Spectral and Structural Studies of a Schiff Base and its Anticorrosive Activity on Mild Steel in H2SO4, New J. Chem., 41: 8459–8468 (2017).
[31] Muscat J., Wander A., Harrison N.M., On the Prediction of Band Gaps from Hybrid Functional Theory, Chem. Phys., 342: 397–401 (2001).
[32] Rienstra-Kiracofe J.C., Barden C.J., Brown S.T., Schaefer H.F., Electron Affinities of Polycyclic Aromatic Hydrocarbons, J. Phys. Chem., 105: 524–528 (2001).
[36] Noureddine O., Gatfaoui S., Brandan S.A., Sagaama A., Marouani H., Issaoui N., Experimental and DFT Studies on the Molecular Structure, Spectroscopic Properties and Molecular Docking of 4-Phenylpiperazine-1-Ium Dihydrogen Phosphate, J. Mol. St., 1207: 127762 (2020).
[38] Ulukaya E., Colakogullari M., Wood E., Interference by Anti-Cancer Chemotherapeutic Agents in the MTT-Tumor Assay, Chemotherapy50: 43–50 (2004).
[39] Florento L., Matias R., Tuano E., Santiago K., Dela Cruz F., Tuazon A., Comparison of Cytotoxic Activity of Anticancer Drugs against Various Human Tumor Cell Lines Using In Vitro Cell-Based Approach, Int. J. Biomed., 8: 76–80 (2012).
[40] Lee M. M.L., Chan B.D., Wong W.Y., Leung T. W., Qu Z., Huang J., Zhu L., Lee C.S., Chen S., Tai W.C.S., Synthesis and Evaluation of Novel Anticancer Compounds Derived from the Natural Product Brevilin A, ACS omega, 5: 14586-14596 (2020).
[41]  Kaur K., Kumar K., Beniwal V., Kumar V., Kumar N., Sharma V., Jaglan S., Synthesis of Some Novel Oxazolidinone-Thiazole Hybrids as Potential Antimicrobial, Antioxidant and UV Mediated DNA Damage Protecting Agents, Med. Chem. Res., 25: 2237-2249 (2016).
[42] Kamal R., Kumar R., Kumar V., Kumar V., Bansal K.K., Sharma P.C., Synthesis, Anthelmintic and Antimicrobial Evaluation of New 2-Arylidene-1-(4-Methyl-6-Phenylpyrimidin-2-yl)Hydrazines, Chem. Select 4: 713-717 (2019).
[43] Singh S., Agnihotri N., Rathi P., Agnihotri R., Kumar V., Molecular Dynamics, Biological Study and extractive Spectrophotometric Determination of Vanadium (V)-2-Methyl-8-Quinolinol Complex, Iran. J. Chem. Chem. Eng. (IJCCE). 40(1): 207-214 (2021).
[45] Joseph S.R, Laura L.T., Evan H.T., David B.C., Method of Continuous Variations: Applications of Job Plots to the Study of Molecular Associations in Organometallic Chemistry, Angewantde Rev., 52: (2013) 11998-12013.
[46] Vosburgh W.C., Cooper G.R., Complex Ions I., The Identification of Complex Ions in Solution by   Spectrophotometric Measurements, J. Am. Chem. Soc., 63: 437-442 (1941).
[47] Yoe J.H., Jones A. L., Colorimetric Determination of Iron with Disodium-1,2-Dihydroxybenzene-3,5-Disulfonate, Ind. Eng. Chem., (Anal. Ed.) 16: 111-115 (1944).
[48] Tarasiewicz H.P., Grudiniewska A., Tarasiewicz M., An Examination of Chlorpromazine Hydrochloride as Indicator and Spectrophotometric Reagent for the Determination of Molybdenum (V), Anal. Chem. Acta.,  94: 435-442 (1977).
[49] Allah M.A.A.H., Balakit A.A.,  Salman H.I.,  Abdulridha A.A., Sert Y., New Heterocyclic Compound as Carbon Steel Corrosion Inhibitor in 1 M H2SO4, High Efficiency at Low Concentration: Experimental and Theoretical Studies, J. Adhes. Sci. Technol., 1-23: (2022) .
[50] Abdulridha A.A.,  Allah M.A.A.H.,  Makki S.Q., Sert Y., Salman H.E.,  Balakit A.A., Corrosion Inhibition of Carbon Steel in 1 M H2SO4 Using New Azo Schiff Compound: Electrochemical, Gravimetric, Adsorption, Surface and DFT Studies, J. Mol. Liq., 315: 113690 (2020).
[51] Kansız S., Tolan A., Azam M., Dege N., Alam M., Sert Y., Al-Resayes S.I., İçbudak H.,  Acesulfame Based Co(II) Complex: Synthesis, Structural Investigations, Solvatochromism, Hirshfeld Surface Analysis and Molecular Docking Studies, Polyhedron,  218: 115762 (2022).
[52] Dege N., Gökce H., Doğan O. E., Alpaslan G., Ağar T., Muthu S.,  Sert Y., Quantum Computational, Spectroscopic Investigations on N-(2-((2-chloro-4,5-Dicyanophenyl)amino)Ethyl)-4-Methylbenzenesulfonamide by DFT/TD-DFT with Different Solvents, Molecular Docking and Drug-Likeness Researches, Colloids Surf.  A Physicochem. Eng. Asp., 638: 128311 (2022).